212 related articles for article (PubMed ID: 15337767)
1. The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.
Finlan L; Hupp TR
J Biol Chem; 2004 Nov; 279(47):49395-405. PubMed ID: 15337767
[TBL] [Abstract][Full Text] [Related]
2. DNA-dependent acetylation of p53 by the transcription coactivator p300.
Dornan D; Shimizu H; Perkins ND; Hupp TR
J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
[TBL] [Abstract][Full Text] [Related]
3. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
[TBL] [Abstract][Full Text] [Related]
4. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.
Dornan D; Shimizu H; Burch L; Smith AJ; Hupp TR
Mol Cell Biol; 2003 Dec; 23(23):8846-61. PubMed ID: 14612423
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
6. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
[TBL] [Abstract][Full Text] [Related]
7. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
[TBL] [Abstract][Full Text] [Related]
8. An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1.
Litterst CM; Pfitzner E
J Biol Chem; 2002 Sep; 277(39):36052-60. PubMed ID: 12138096
[TBL] [Abstract][Full Text] [Related]
9. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
10. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.
Craig A; Scott M; Burch L; Smith G; Ball K; Hupp T
EMBO Rep; 2003 Aug; 4(8):787-92. PubMed ID: 12897801
[TBL] [Abstract][Full Text] [Related]
11. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
Burch LR; Scott M; Pohler E; Meek D; Hupp T
J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
[TBL] [Abstract][Full Text] [Related]
12. Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
Jowsey PA; Doherty AJ; Rouse J
J Biol Chem; 2004 Dec; 279(53):55562-9. PubMed ID: 15456759
[TBL] [Abstract][Full Text] [Related]
13. Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.
Teufel DP; Bycroft M; Fersht AR
Oncogene; 2009 May; 28(20):2112-8. PubMed ID: 19363523
[TBL] [Abstract][Full Text] [Related]
14. p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300.
Livengood JA; Scoggin KE; Van Orden K; McBryant SJ; Edayathumangalam RS; Laybourn PJ; Nyborg JK
J Biol Chem; 2002 Mar; 277(11):9054-61. PubMed ID: 11782467
[TBL] [Abstract][Full Text] [Related]
15. Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.
Teufel DP; Freund SM; Bycroft M; Fersht AR
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7009-14. PubMed ID: 17438265
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300.
Dornan D; Hupp TR
EMBO Rep; 2001 Feb; 2(2):139-44. PubMed ID: 11258706
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.
Bouras T; Fu M; Sauve AA; Wang F; Quong AA; Perkins ND; Hay RT; Gu W; Pestell RG
J Biol Chem; 2005 Mar; 280(11):10264-76. PubMed ID: 15632193
[TBL] [Abstract][Full Text] [Related]
18. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription.
Lee D; Kim JW; Seo T; Hwang SG; Choi EJ; Choe J
J Biol Chem; 2002 Jun; 277(25):22330-7. PubMed ID: 11950834
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
20. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
